Comments of the Healthcare Supply Chain Association (HSCA) on USTR Request for Comments on the Proposed Modification of Action Pursuant to Section 301
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on the proposed modification of action regarding Chinese exports under Section 301.
Click here for the full comments.
Related Posts
Group Comment Letter to FDA on Clinical Immunogenicity Considerations from Biosimilar and Interchangeable Insulin Products
January 28, 2020
Dear Commissioner Hahn, The undersigned groups share the Food and Drug...
Comments of the Healthcare Supply Chain Association to FDA on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions
January 11, 2019
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Submits Comments to FDA on Using Unique Device Identifiers in Medical Device Safety Communications to Support Accuracy, Quality, and Patient Safety
January 18, 2021
Washington, DC (January 19, 2021) – The Healthcare Supply Chain Association...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...